ASSA ABLOY acquires PACLOCK in the US
"I am very pleased to welcome PACLOCK to ASSA ABLOY. This acquisition delivers on our strategy to strengthen our position in mature markets through adding complementary products and solutions to our core business," says
"PACLOCK is recognized for delivering high-quality security products that combine reliability, durability, and innovation, backed by US-based manufacturing and exceptional customer service," says
PACLOCK was founded in 1998 and has some 40 employees. The main office and factory are located in
Sales for 2025 amounted to about MUSD 17 (approx. MSEK 155) with a strong EBIT margin. The acquisition will be accretive to EPS from the start.
About ASSA ABLOY
ASSA ABLOY is the global leader in access solutions. Every day we help people feel safe, secure and experience a more open world. We operate worldwide with 64,000 employees and sales of SEK 152 billion, with leading positions in areas such as efficient door openings, trusted identities and entrance automation. Our innovations enable safe, secure and convenient access to physical and digital places.
For more information, please contact:
Nico Delvaux, President and CEO, tel. no: +46 8 506 485 82
Erik Pieder, CFO and Executive Vice President, tel. no: +46 8 506 485 72
Björn Tibell, Head of Investor Relations, tel. no: +46 70 275 67 68, E-mail: [email protected]
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/assa-abloy/r/assa-abloy-acquires-paclock-in-the-us,c4396577
The following files are available for download:
|
Press release (PDF) |
|
|
https://news.cision.com/assa-abloy/i/paclock-usa-1---16x9,c3565610 |
PACLOCK USA 1 - 16x9 |
View original content:https://www.prnewswire.com/news-releases/assa-abloy-acquires-paclock-in-the-us-302880181.html
SOURCE ASSA ABLOY
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nirvik Singh to Join Monks International Leadership Team and, as a First Step, Lead EMEA Business, Accelerating Regional Growth and Real-Time Marketing
- PureTech Announces Successful End-of-Phase 1 Meeting with U.S. Food and Drug Administration (FDA) and Receipt of Fast Track Designation for LYT-200 in Relapsed/Refractory (R/R) High-Risk Myelodysplast
- Medincell's Partner Teva Presented New Data on Investigational Olanzapine LAI and UZEDY® at Psych Congress 2026
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share